BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Bioinformatics on the Brink (The Scientist)
News | 12. 20. 2004
Companies struggle to diversify after disappointing software sales sink the sector.
